Skip To Main Content
Amriti R. Lulla on Muck Rack

Amriti R. Lulla

As seen in: Color Research & Application, Texas Medical Center
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Amriti R.

Contact Amriti R., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Low-Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer

|
By Amriti R. Lulla
| Texas Medical Center
Abstract Cyclin E is a regulatory subunit of CDK2 that mediates S phase entry and progression. The cleavage of full-length cyclin E (FL-cycE) to low-molecular weight isoforms (LMW-E) dramatically alters substrate specificity, promoting G1-S cell cycle transition and accelerating mitotic exit. Approximately 70% of triple-negative breast cancers (TNBC) express LMW-E, which correlates with poor prognosis.
Open in Who Shared Issue with article?

From TRAIL to ONC201: Case Study on the Safety Benefit of Developing Targeted Agents Against Cancer‐selective Pathways

|
By Jessica Wagner, Amriti R. Lulla, Marie D Ralff, Lanlan Zhou
| Color Research & Application Verified
A major goal of drug development is to end up with a safe and effective therapy for a disease such as cancer. We describe our experience with taking the small molecule ONC201/TIC10 from the lab to clinical trials. The path involved a phenotypic drug screen to identify a small molecule that activates a pathway that has been established as cancer specific – the TRAIL pathway.
Open in Who Shared Issue with article?

Bcl-2 Protein Targeting by the p53/p21 Complex-Letter

|
By Rahmat Sikder, Amriti R. Lulla, Prashanth Gokare, Xiaobing Tian
| cancerres.aacrjournals.org
Letter to the Editor Bcl-2 Protein Targeting by the p53/p21 Complex—Letter Liz J. Hernandez Borrero, Rahmat Sikder, Amriti Lulla, Prashanth Gokare, Paulo R. Del Valle, Xiaobing Tian, Shengliang Zhang, Philip H. Abbosh and Wafik S. El-Deiry
Open in Who Shared Issue with article?
See all 11 articles